NCT07790614Recruiting
Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
The CT-IPF ANTHEM study is designed to prospectively compare PCDCT to HRCT scan in the identification of specific ILD diagnosis discussed during the multidisciplinary discussion to increase diagnostic confidence and reduce unclassifiable ILD cases.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 156 (estimated)
- First submitted
- 5 May 2026
- Start date
- 25 Mar 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Istituto Clinico Humanitas
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT07790614
What you commit to
- Study type: Observational
- Planned participants: 156
- From 25 Mar 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Interstitial abnormalities that could be explained by causes different than ILD (e.g.: heart failure; viral)
Other
- Patients with acute exacerbation of ILD
Who the study is looking for
- ≥ 18 years of age
- Any gender
- Any race
- Signed informed consent
- ILD diagnosis with the need for a multidisciplinary discussion
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Humanitas Research Hospital Coordinator of this site? Confirm its status | Rozzano | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.